Missouri 2025 Regular Session

Missouri Senate Bill SB94

Introduced
1/8/25  
Refer
1/16/25  
Engrossed
2/27/25  
Refer
3/25/25  
Report Pass
4/17/25  
Refer
5/7/25  
Report Pass
5/12/25  

Caption

Modifies provisions relating to health care

Impact

If enacted, SB94 will significantly impact existing healthcare statutes by reinforcing coverage requirements for hormonal contraceptives and ensuring that such benefits are accessible without excessive financial burdens. This change means that more individuals will have improved access to reproductive health care, which may lead to a reduction in unwanted pregnancies and better health outcomes. Proponents argue that this legislation represents a necessary step towards equitable health care access, particularly for women.

Summary

SB94 seeks to modify provisions relating to health care, particularly focusing on the coverage of self-administered hormonal contraceptives. The bill mandates that health benefit plans issued on or after January 1, 2026, must cover reimbursements to healthcare providers or dispensing entities for a year's supply of such contraceptives. Additionally, it sets regulations that the coverage for these contraceptives should not be subjected to greater deductibles or co-payments than those imposed on other similar healthcare services. This shift aligns with broader legislative goals to improve access to reproductive health options in the state.

Sentiment

The general sentiment around SB94 is supportive among health advocacy groups, healthcare providers, and many legislators who view it as a progressive measure to ensure reproductive health access. However, there are concerns from some groups regarding the implications for insurance premiums and coverage scopes, particularly around the costs this may impose on health carriers. The dialogue surrounding the bill indicates a passionate commitment to reproductive rights coupled with apprehensions about the financial viability of such mandates in the broader health insurance market.

Contention

Notable points of contention include debates over whether mandated coverage for hormonal contraceptives might lead to increased premiums for all insured individuals and how this bill aligns with individual and organizational beliefs about contraceptive use. Opponents argue that imposing such coverage might infringe on the rights of employers who oppose contraception on moral or religious grounds. The bill's proponents respond by emphasizing the importance of personal choice in reproductive health and the public health benefits associated with improved access to contraception.

Companion Bills

No companion bills found.

Previously Filed As

MO SB45

Modifies provisions relating to health care

MO HB2824

Modifies provisions relating to health care

MO HB2413

Modifies provisions relating to health care

MO HB2175

Modifies provisions relating to health care

MO HB1060

Modifies provisions relating to MO HealthNet benefits

MO HB1082

Modifies provisions relating to mental health care

MO HB402

Modifies provisions relating to health care

MO HB1094

Modifies provisions relating to mental health care

MO HB2808

Modifies provisions relating to health care facilities

MO SB183

Modifies provisions relating to MO HealthNet eligibility and services

Similar Bills

TX HB2283

Relating to the use of an epinephrine delivery device by certain entities.

TX SB1619

Relating to the use of an epinephrine delivery system by certain entities.

CA SB568

Pupil health: epinephrine delivery systems: schoolsites and childcare programs.

TX HB2801

Relating to the definition of an epinephrine delivery device and the use of those devices in public and private schools.

MO HB222

Establishes provisions relating to allergy prevention and responses in child care facilities

CA AB228

Pupil health: epinephrine delivery systems.

CA AB2714

Pupil health: epinephrine delivery systems.

WI SB7

Use of epinephrine delivery systems and standing orders for epinephrine. (FE)